 |
E. S. “Stan” Eskridge, Jr.
CEO, President and Co-founder: 25 years of experience in company development and technology deployment. Experienced in business planning, capital formation, business development, strategic alliances and marketing. Member of the Board of Directors.
|
 |
Thomas H. Fischer, Ph.D.
Vice President, CSO and Co-founder: 20 years of hematology research, Scientific Director of the Francis Owen Blood Research Laboratory at the University of North Carolina at Chapel Hill. Inventor of the Stasilon™ and Stasix technologies.
|
 |
Richard E. Martin, CPA
Vice President, CFO: more than 25 years of experience in accounting, finance, and operations with emphasis on healthcare services and technology companies. Significant experience with financing biotechnology, specialty pharmaceutical, and early stage technology companies. Broad finance and operations background including public companies, strategic partnering, manufacturing, international operations, and public accounting.
|
|
Carr J. Smith, Ph.D.
Vice President of Product Development: experienced toxicologist, appointed Diplomat of the American Board of Toxicology in 1994. Former member of the Internal Review Board (IRB) at the Wake Forest University School of Medicine. Extensive experience in contracting for external corporate research and project management. |
 |
Joseph A. DaCorta
Chief Technical Officer: more than 25 years of healthcare experience in bio-defense and homeland security. Retired Navy Medical Service Corps officer and once served as Head of Expeditionary Medicine at the US Marine Corps Warfighting Laboratory where he tested technologies relating to combat trauma and environmental health problems. Experience in federal acquisition procedures, global commercialization and formations of public and private partnerships.
|
 |
|
Richard A. Kendall
Vice President, Sales & Marketing: Brings strong executive leasdership and over 18 years of experience in the medical device industry including sales, sales manaagement, marketing, business development and operations. Mr. Kendall's prior experience include; Sales and Sales Opeations Director for Baxter Healthcare's BioSurgery division and Vice President of Sales for Covidien's Sports Surgery division. Mr. Kendall's extensive experience of building organizations within the medical device industry will help Entegrion successfully commercialize their product portfolio.
|
|
 |
Meredith E. Mannheim
Director of Operations: more than 15 years of experience in marketing, business development and project management focusing on creative direction and implementation of consumer interactive and Internet-related services for both start-up and growth companies. |
|
|
Bronwen Nishikawa, Ph.D.
Director of Patents and Trademarks: formerly Manager of Intellectual Property with KaroBio USA, Inc., and Technology Development Associate with the Office of Technology Development with the University of North Carolina at Chapel Hill. |
 |
Mike Galiger
Manufacturing and Engineering Manager: More than 10 years of experience in medical and consumer products industries. A successful track record in new product development, manufacturing start-up, and plant engineering. Formerly served as the director of new product development and strategic sourcing at Charter Medical. |
|
|
 |
|
Lori Savage
Office Administrative Assistant: Mrs. Savage joined Entegrion in January 2008 and has a degree in Business Management from Radford University. Her prior experience includes Meeting and Event Planning for the National Association of Credit Management in Tampa, Florida, as well as being the Executive Assistant for the Vice President of Marketing for SITA, an airline transport and IT solutions company located in Atlanta, Georgia.
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|